This grant offered by the National Institute of Neurological Disorders and Stroke is to support research for the discovery and preclinical testing of new compounds aimed at preventing and treating nervous system disorders. The application deadline for this opportunity is on January 7, 2019.
Opportunity ID: 280239
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-16-042 |
Funding Opportunity Title: | Drug Discovery For Nervous System Disorders (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Nov 24, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | Jan 07, 2019 |
Current Closing Date for Applications: | Jan 07, 2019 |
Archive Date: | Feb 07, 2019 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal governments (Federally recognized) For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-16-042.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00219776 | Jan 16, 2016 | May 07, 2016 | View | |
FORMS-D | Use for due dates on or before January 24, 2018 | PKG00222529 | Apr 17, 2016 | Jan 24, 2018 | View | |
FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236117 | Nov 13, 2017 | Jan 07, 2019 | View |
Package 1
Mandatory forms
280239 RR_SF424_2_0-2.0.pdf
280239 PHS398_ResearchPlan_2_0-2.0.pdf
280239 PHS398_CoverPageSupplement_2_0-2.0.pdf
280239 RR_KeyPersonExpanded_2_0-2.0.pdf
280239 RR_OtherProjectInfo_1_3-1.3.pdf
280239 PerformanceSite_2_0-2.0.pdf
Optional forms
280239 RR_SubawardBudget30_1_3-1.3.pdf
280239 PlannedReport-1.0.pdf
280239 PHS398_CumulativeInclusionReport-1.0.pdf
280239 PHS398_ModularBudget_1_2-1.2.pdf
280239 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
280239 RR_SF424_2_0-2.0.pdf
280239 PHS398_CoverPageSupplement_3_0-3.0.pdf
280239 RR_OtherProjectInfo_1_3-1.3.pdf
280239 PerformanceSite_2_0-2.0.pdf
280239 RR_KeyPersonExpanded_2_0-2.0.pdf
280239 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
280239 RR_Budget_1_3-1.3.pdf
280239 RR_SubawardBudget30_1_3-1.3.pdf
280239 PHS398_ModularBudget_1_2-1.2.pdf
280239 PHS_Inclusion_Enrollment_Report-1.0.pdf
280239 PHS_AssignmentRequestForm-1.0.pdf
Package 3
Mandatory forms
280239 RR_SF424_2_0-2.0.pdf
280239 PHS398_CoverPageSupplement_4_0-4.0.pdf
280239 RR_OtherProjectInfo_1_4-1.4.pdf
280239 PerformanceSite_2_0-2.0.pdf
280239 RR_KeyPersonExpanded_2_0-2.0.pdf
280239 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
280239 RR_Budget_1_4-1.4.pdf
280239 RR_SubawardBudget30_1_4-1.4.pdf
280239 PHS398_ModularBudget_1_2-1.2.pdf
280239 PHS_AssignmentRequestForm_2_0-2.0.pdf